Lixi Li
Impact in
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism
-
- Cancer Genomics and Diagnostics
Papers in
-
- Head and Neck Cancer Studies 8
- Oncology 28
- HER2/EGFR in Cancer Research 10
- Ear and Head Tumors 6
Lixi Li
76 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 116
- Neurology 92
- Cancer Research 155
- Oncology 263
- Physiology 194
- Cellular and Molecular Neuroscience 125
Countries citing papers authored by Lixi Li
This map shows the geographic impact of Lixi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixi Li more than expected).
Fields of papers citing papers by Lixi Li
This network shows the impact of papers produced by Lixi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixi Li. The network helps show where Lixi Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lixi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 27 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2020 | 10 | |
| 16 | 2020 | 2 | |
| 17 | 2019 | 13 | |
| 18 | 2019 | 32 | |
| 19 | 2017 | 24 | |
| 20 | 2016 | 26 |
About Lixi Li
Lixi Li is a scholar working on Otorhinolaryngology, Oncology, Cancer Research, Health Informatics and Pulmonary and Respiratory Medicine, having authored 79 papers that have together received 1.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Cancer Genomics and Diagnostics (9 papers), Head and Neck Cancer Studies (8 papers), Salivary Gland Tumors Diagnosis and Treatment (8 papers), Advanced Breast Cancer Therapies (6 papers), Ear and Head Tumors (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Neurology (92 citations), Cancer Research (155 citations), Oncology (263 citations), Physiology (194 citations) and Cellular and Molecular Neuroscience (125 citations). Lixi Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fei Ma, Weidong Le, Xin Zhang, Zongbi Yi, Xiuwen Guan, Binliang Liu, Dehua Yang, Yunlan Du, Rachelle S. Doody and Xin Heng. Their work appears in journals such as The Breast, Journal of Clinical Oncology, Journal of Clinical Medicine, European Archives of Oto-Rhino-Laryngology and Journal of Functional Foods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.